ARCHIVES

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

This article is from The Cancer Letter archive.

Vol. 25 No. 3 | March 29, 2002

Download PDF Visit The Full Archive

Related Articles

Phase II ThermoDox Trial Demonstrates Positive Response

August 29, 2014

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

November 1, 2012

Schering to Pay $435M to Settle Federal Charges.

January 26, 2007

NCAB Recommends Withdrawal Of CRCC Comprehensive Status

February 13, 1981

KnowMed Buys CancerSource.com Subsidiary Of Jones & Bartlet Publishers.

December 1, 2000

Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention

January 21, 2011